These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26334678)

  • 1. Research participant compensation: A matter of statistical inference as well as ethics.
    Swanson DM; Betensky RA
    Contemp Clin Trials; 2015 Nov; 45(Pt B):265-269. PubMed ID: 26334678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different parametric proportional hazards models for interval-censored data: a simulation study.
    Gong Q; Fang L
    Contemp Clin Trials; 2013 Sep; 36(1):276-83. PubMed ID: 23916917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust inference in discrete hazard models for randomized clinical trials.
    Nguyen VQ; Gillen DL
    Lifetime Data Anal; 2012 Oct; 18(4):446-69. PubMed ID: 22810273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of censoring on learning Bayesian networks in survival modelling.
    Stajduhar I; Dalbelo-Basić B; Bogunović N
    Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of censoring on conclusions of trials for women with metastatic breast cancer.
    Templeton AJ; Ace O; Amir E; Vera-Badillo F; Ocana A; Pond GR; Tannock IF
    Eur J Cancer; 2015 Apr; 51(6):721-4. PubMed ID: 25728257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of censoring on progression free survival: oncologist discretion advised.
    Prasad V; Bilal U
    Eur J Cancer; 2015 Nov; 51(16):2269-71. PubMed ID: 26259493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covariate-adjusted non-parametric survival curve estimation.
    Jiang H; Symanowski J; Qu Y; Ni X; Wang Y
    Stat Med; 2011 May; 30(11):1243-53. PubMed ID: 21344475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint models for efficient estimation in proportional hazards regression models.
    Slasor P; Laird N
    Stat Med; 2003 Jul; 22(13):2137-48. PubMed ID: 12820279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonignorable censoring in randomized clinical trials.
    Zhang J; Heitjan DF
    Clin Trials; 2005; 2(6):488-96. PubMed ID: 16422309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulation studies on the estimation of total area under the curve in the presence of right-tailed censoring.
    Bonate PL
    J Pharmacokinet Pharmacodyn; 2015 Feb; 42(1):19-32. PubMed ID: 25367741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inference for the effect of treatment on survival probability in randomized trials with noncompliance and administrative censoring.
    Nie H; Cheng J; Small DS
    Biometrics; 2011 Dec; 67(4):1397-405. PubMed ID: 21385167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semiparametric estimation of proportional mean residual life model in presence of censoring.
    Chen YQ; Jewell NP; Lei X; Cheng SC
    Biometrics; 2005 Mar; 61(1):170-8. PubMed ID: 15737090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymptotic properties of mean survival estimate based on the Kaplan-Meier curve with an extrapolated tail.
    Gong Q; Fang L
    Pharm Stat; 2012; 11(2):135-40. PubMed ID: 22323424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity and efficiency of approximation methods for tied survival times in Cox regression.
    Hertz-Picciotto I; Rockhill B
    Biometrics; 1997 Sep; 53(3):1151-6. PubMed ID: 9333345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new modeling and inference approach for the Systolic Blood Pressure Intervention Trial outcomes.
    Yang S; Ambrosius WT; Fine LJ; Bress AP; Cushman WC; Raj DS; Rehman S; Tamariz L
    Clin Trials; 2018 Jun; 15(3):305-312. PubMed ID: 29671345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple test for independent censoring under the proportional hazards model.
    Lee SY; Wolfe RA
    Biometrics; 1998 Sep; 54(3):1176-82. PubMed ID: 9840972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of the discrete-time Kaplan-Meier estimate to nonignorable censoring: Application in a clinical trial.
    Liu T; Heitjan DF
    Stat Med; 2012 Nov; 31(25):2998-3010. PubMed ID: 22806989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiparametric inference for surrogate endpoints with bivariate censored data.
    Ghosh D
    Biometrics; 2008 Mar; 64(1):149-56. PubMed ID: 17651457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study).
    Yoshida M; Matsuyama Y; Ohashi Y;
    Clin Trials; 2007; 4(4):318-28. PubMed ID: 17848493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.